**Question:** Bacteria and fungi share some common mechanisms of resistance to drugs used in treatment of bacterial or fungal infection. However, bacteria have a resistance mechanism not described in fungi. This mechanism is

A. Modification of the drug target
B. Induction of drug efflux pumps
C. Alteration of drug permeability
D. Induction of drug inactivation enzymes

**Correct Answer:** A. Modification of the drug target

**Core Concept:**

Bacterial resistance to antimicrobial agents can occur through various mechanisms, including changes in the drug target. When a drug target is modified, the drug loses its ability to bind to its intended cellular target, reducing the drug's effectiveness. In contrast, fungi primarily develop resistance through other mechanisms, such as drug efflux pumps, alteration of drug permeability, or induction of drug inactivation enzymes.

**Why the Correct Answer is Right:**

In bacteria, one common mechanism for resistance involves alteration or modification of the drug target. This could be due to mutations in the gene encoding the target protein, leading to changes in the target structure and reduced binding affinity for the drug. For example, in the case of beta-lactam antibiotics like penicillin, the bacteria can acquire a beta-lactamase enzyme, which hydrolyzes the beta-lactam ring, rendering the antibiotic inactive.

**Why Each Wrong Option is Incorrect:**

A. **Modification of the drug target (Option A)** is correct, as mentioned above.

B. **Induction of drug efflux pumps (Option B)** is a common mechanism in fungi, not bacteria. Efflux pumps are proteins that actively pump the antimicrobial agent out of the cell, preventing it from reaching its target site.

C. **Alteration of drug permeability (Option C)** is also more relevant to fungal resistance mechanisms. Alterations in the cell membrane or the cell wall structure can affect the drug's ability to penetrate the cell and reach its target site.

D. **Induction of drug inactivation enzymes (Option D)** is a mechanism often seen in fungi. These enzymes can degrade the antimicrobial agent, rendering it inactive before it reaches its target site.

**Clinical Pearl:**

Understanding the various mechanisms of antimicrobial resistance is crucial for effective treatment planning. While bacteria and fungi share some resistance mechanisms (e.g., efflux pumps in fungi and beta-lactamases in bacteria), the correct answer in this question pertains to bacterial resistance mechanisms. In this case, the correct answer is modification of the drug target, which is unique to bacteria and not seen in fungi.